Safety of green tea extracts : a systematic review by the US Pharmacopeia
- PMID: 18484782
- DOI: 10.2165/00002018-200831060-00003
Safety of green tea extracts : a systematic review by the US Pharmacopeia
Abstract
Green tea [Camellia sinensis (L.) Kuntze] is the fourth most commonly used dietary supplement in the US. Recently, regulatory agencies in France and Spain suspended market authorization of a weight-loss product containing green tea extract because of hepatotoxicity concerns. This was followed by publication of adverse event case reports involving green tea products. In response, the US Pharmacopeia (USP) Dietary Supplement Information Expert Committee (DSI EC) systematically reviewed the safety information for green tea products in order to re-evaluate the current safety class to which these products are assigned. DSI EC searched PubMed (January 1966-June 2007) and EMBASE (January 1988-June 2007) for clinical case reports and animal pharmacological or toxicological information. Reports were also obtained from a diverse range of other sources, including published reviews, the US FDA MedWatch programme, USP's MEDMARX adverse event reporting system, the Australian Therapeutic Goods Administration, the UK Medicines and Healthcare products Regulatory Agency, and Health Canada's Canadian Adverse Drug Reaction Monitoring Program. Case reports pertaining to liver damage were evaluated according to the Naranjo causality algorithm scale. In addition, the Committee analysed information concerning historical use, regulatory status, and current extent of use of green tea products. A total of 216 case reports on green tea products were analysed, including 34 reports concerning liver damage. Twenty-seven reports pertaining to liver damage were categorized as possible causality and seven as probable causality. Clinical pharmacokinetic and animal toxicological information indicated that consumption of green tea concentrated extracts on an empty stomach is more likely to lead to adverse effects than consumption in the fed state. Based on this safety review, the DSI EC determined that when dietary supplement products containing green tea extracts are used and formulated appropriately the Committee is unaware of significant safety issues that would prohibit monograph development, provided a caution statement is included in the labelling section. Following this decision, USP's DSI ECs may develop monographs for green tea extracts, and USP may offer its verification programmes related to that dietary ingredient.
Similar articles
-
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.Toxicol Rep. 2020 Feb 15;7:386-402. doi: 10.1016/j.toxrep.2020.02.008. eCollection 2020. Toxicol Rep. 2020. PMID: 32140423 Free PMC article. Review.
-
United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.Menopause. 2008 Jul-Aug;15(4 Pt 1):628-38. doi: 10.1097/gme.0b013e31816054bf. Menopause. 2008. PMID: 18340277 Review.
-
United States pharmacopeia safety evaluation of spirulina.Crit Rev Food Sci Nutr. 2011 Aug;51(7):593-604. doi: 10.1080/10408391003721719. Crit Rev Food Sci Nutr. 2011. PMID: 21793723 Review.
-
The state of dietary supplement adverse event reporting in the United States.Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):962-70. doi: 10.1002/pds.1627. Pharmacoepidemiol Drug Saf. 2008. PMID: 18613260 Review.
-
Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements.Toxicol Lett. 2017 Aug 5;277:104-108. doi: 10.1016/j.toxlet.2017.06.008. Epub 2017 Jun 24. Toxicol Lett. 2017. PMID: 28655517 Review.
Cited by 69 articles
-
Scientific opinion on the safety of green tea catechins.EFSA J. 2018 Apr 18;16(4):e05239. doi: 10.2903/j.efsa.2018.5239. eCollection 2018 Apr. EFSA J. 2018. PMID: 32625874 Free PMC article.
-
An educational intervention improved knowledge of dietary supplements in college students.BMC Public Health. 2020 May 7;20(1):633. doi: 10.1186/s12889-020-08786-3. BMC Public Health. 2020. PMID: 32381078 Free PMC article.
-
United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.Toxicol Rep. 2020 Feb 15;7:386-402. doi: 10.1016/j.toxrep.2020.02.008. eCollection 2020. Toxicol Rep. 2020. PMID: 32140423 Free PMC article. Review.
-
Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review.Int J Mol Sci. 2019 Dec 8;20(24):6196. doi: 10.3390/ijms20246196. Int J Mol Sci. 2019. PMID: 31817990 Free PMC article. Review.
-
Effect of Acute Ingestion of Green Tea Extract and Lemon Juice on Oxidative Stress and Lipid Profile in Pigs Fed a High-Fat Diet.Antioxidants (Basel). 2019 Jun 23;8(6):195. doi: 10.3390/antiox8060195. Antioxidants (Basel). 2019. PMID: 31234608 Free PMC article.